版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、寧夏醫(yī)科大學(xué)碩士學(xué)位論文ATM、DNA-PKcs在宮頸癌組織中的表達(dá)及與放療敏感性的研究姓名:王秋申請(qǐng)學(xué)位級(jí)別:碩士專業(yè):腫瘤學(xué)指導(dǎo)教師:折虹20100401寧夏醫(yī)科大學(xué)碩士研究生學(xué)位論文 英文摘要 Ⅱ The relationship of radiosensitivity and the expression
2、 of ATM and DNA-PKcs in human cervical carcinoma ABSTRACT Objective To study the relationship of radiosensitivity and expression of ATM and DNA-PKcs in human cervical carcinoma. Methods Immunohistochemistry was used
3、 to detect the expression of ATM and DNA-PKcs for 50 patients with cervical carcinoma and 20 patients with normal cervical tissue.Dased on the current radiotherapy,the patients of cervical carcinoma were divided into two
4、 groups,which were high radiosensitive and low radiosensitive .The expression of the two proteins,ATM and DNA-PKcs,were campared, and combined with clinical data, were analized the relationship with patients’ age, clinic
5、al stage and differentiation. Results (1)The positive percentages of ATM in cervical carcinoma and normal cervical tissue were 22% and 60% respectively, the differences had statistical significance(P<0.05).(2)The posi
6、tive percentages of DNA-PKcs in cervical carcinoma and normal cervical tissue were 62% and 40% respectively, the differences had no statistical significance (P>0.05).(3)The expression of DNA-PKcs in cervical carcinoma wa
7、s higher than ATM, the difference had statistical significance (P<0.05).(4) In 50 cases of cervical carcinoma after radiotherapy, CR is 48% (24/50), PR is 52% (26/50).(5)The expression of ATM and DNA-PKcs in high radiose
8、nsitive group and low radiosensitive group were 8.3% and 34.6%、45.8% and 76.9% respectively, the differences of both had statistical significance (P<0.05).(6) Spearman correlation analysis showed that the expression of A
9、TM and DNA-PKcs in cervical carcinoma had no correlation(r=0.251 P=0.078).(7)The differences of ATM and DNA-PKcs between different cervical carcinoma patients’ ages, clinical stages and differentiations had no statistic
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- DNA-PKcs在食管鱗癌細(xì)胞放療敏感性中的作用及機(jī)制.pdf
- 沉默DNA-PKcs、ATM表達(dá)對(duì)HeLa細(xì)胞生物學(xué)行為及放療敏感性的影響.pdf
- 宮頸癌放療敏感性相關(guān)基因的篩選.pdf
- 外源性PUMA表達(dá)增加HPV陽性宮頸癌放療敏感性的體外研究.pdf
- miR--145在宮頸癌放療敏感性調(diào)節(jié)中的作用及機(jī)制研究.pdf
- TGFβ1、DNA-PKcs在宮頸癌組織及細(xì)胞株放療前后蛋白表達(dá)變化與近期療效的相關(guān)性初探.pdf
- DNA-PKcs、MGMT在肝癌組織中的表達(dá)及意義.pdf
- Sp1對(duì)宮頸癌放療敏感性的影響及其機(jī)制研究.pdf
- MiR-181a通過靶向PRKCD調(diào)節(jié)宮頸癌放療敏感性.pdf
- KLF4抑制宮頸癌放療敏感性及其分子機(jī)制研究.pdf
- MTDH對(duì)宮頸癌生物學(xué)行為及化療、放療敏感性的影響及機(jī)制研究.pdf
- 局部晚期宮頸癌組織中Fas-FasL的表達(dá)與同步放化療敏感性及療效的關(guān)系.pdf
- 胃癌中ERCCI、DNA-PKcs蛋白的表達(dá).pdf
- 肺腺磷癌組織中miRNA表達(dá)譜的變化與放療敏感性的關(guān)系.pdf
- DNA-PKcs在非小細(xì)胞肺癌組織中的表達(dá)及臨床意義.pdf
- 預(yù)測(cè)宮頸癌新輔助化療的敏感性研究進(jìn)展.pdf
- MicroRNA-218通過促進(jìn)細(xì)胞凋亡增強(qiáng)宮頸癌放療敏感性.pdf
- 宮頸鱗癌組織中P73α,ATM表達(dá)水平與放射敏感性及預(yù)后相關(guān)性研究.pdf
- 中、晚期宮頸癌PCNA、Ki-67的表達(dá)與放射敏感性及臨床預(yù)后的相關(guān)性研究.pdf
- E1A通過E6-E6AP增強(qiáng)宮頸癌放療敏感性的機(jī)制研究.pdf
評(píng)論
0/150
提交評(píng)論